Crescent Capital BDC, Inc. (NASDAQ:CCAP – Get Free Report)’s stock price hit a new 52-week high on Tuesday . The stock traded as high as $20.19 and last traded at $20.03, with a volume of 8674 shares changing hands. The stock had previously closed at $19.95.
Analysts Set New Price Targets
Several analysts recently weighed in on the company. Wells Fargo & Company increased their target price on Crescent Capital BDC from $18.00 to $19.00 and gave the company an “equal weight” rating in a research note on Wednesday, January 29th. Keefe, Bruyette & Woods raised their price objective on Crescent Capital BDC from $19.00 to $20.00 and gave the stock an “outperform” rating in a research report on Monday, November 25th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, Crescent Capital BDC currently has an average rating of “Moderate Buy” and an average target price of $19.33.
Read Our Latest Stock Analysis on CCAP
Crescent Capital BDC Price Performance
Crescent Capital BDC (NASDAQ:CCAP – Get Free Report) last issued its earnings results on Wednesday, February 19th. The company reported $0.55 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.56 by ($0.01). Crescent Capital BDC had a return on equity of 12.20% and a net margin of 47.06%. The company had revenue of $46.40 million during the quarter, compared to analyst estimates of $47.27 million. On average, equities analysts expect that Crescent Capital BDC, Inc. will post 2.43 EPS for the current year.
Crescent Capital BDC Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Monday, March 31st will be issued a $0.42 dividend. The ex-dividend date is Monday, March 31st. This represents a $1.68 dividend on an annualized basis and a dividend yield of 8.81%. Crescent Capital BDC’s payout ratio is presently 65.88%.
Hedge Funds Weigh In On Crescent Capital BDC
A number of hedge funds have recently modified their holdings of CCAP. Montag A & Associates Inc. acquired a new position in shares of Crescent Capital BDC in the 4th quarter worth approximately $35,000. C M Bidwell & Associates Ltd. acquired a new stake in Crescent Capital BDC during the 4th quarter valued at $39,000. Aquatic Capital Management LLC acquired a new stake in Crescent Capital BDC during the 4th quarter valued at $129,000. Generation Capital Management LLC acquired a new stake in Crescent Capital BDC during the 4th quarter valued at $192,000. Finally, Dynamic Technology Lab Private Ltd acquired a new stake in Crescent Capital BDC during the 4th quarter valued at $218,000. 49.46% of the stock is owned by institutional investors and hedge funds.
Crescent Capital BDC Company Profile
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
See Also
- Five stocks we like better than Crescent Capital BDC
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- Comparing and Trading High PE Ratio Stocks
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- What is a Bond Market Holiday? How to Invest and Trade
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.